Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
References (41)
A simple screening procedure for imipramine-like antidepressant agents
Life Sci.
(1963)- et al.
Release of norepinephrine in the central nervous system by theophylline and caffeine
Eur. J. Pharmac.
(1970) - et al.
Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines
Eur. J. Pharmac.
(1979) Effect of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain
Eur. J. Pharmac.
(1978)- et al.
In vivo effects of apomorphine and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) on cyclic nucleotides in rat brain and pituitary
Biochem. Pharmac.
(1980) - et al.
Effect of theophylline on monoamine metabolism in the rat brain
Eur. J. Pharmac.
(1976) - et al.
The role of cyclic nucleotides in the in vivo synthesis of catecholamines in rat brain
- et al.
Effect of pentoxifylline on α- and β-adrenoceptor sites in cerebral cortex, medial basal hypothalamus and pineal gland of the rat
Neuropharmacology
(1982) - et al.
Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents
Eur. J. Pharmac.
(1967) - et al.
Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity
Psychopharmacologia
(1973)
Is adenylate cyclase the dopamine receptor?
Med. Biol.
Effect of psychotropic drugs on uptake of 3H-norepinephrine by tissue
Science
Effect of reserpine on monoamine synthesis and on apparent dopaminergic receptor sensitivity in rat brain
The biochemistry of affective disorders
Br. J. Psychiat.
Effects of caffeine on central monoamine neurons
J. Pharm. Pharmac.
Effects of drugs on uptake of isotopic norepinephrine by cat tissues
Nature
Isolation from rat brain of a metabolic product, demethylimipramine, that mediates the antidepressant activity of imipramine
Experientia
Catecholamine uptake by synaptosomes from rat brain. Structure activity relationships of drugs with differential effects on dopamine and norepinephrine neurons
Molec. Pharmac.
3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo
J. Neural Trans.
Regulation of the in vivo synthesis of brain dopamine by presynaptic receptors
Cited by (230)
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance
2021, European Journal of Medicinal ChemistryRole of tau protein in Alzheimer's disease: The prime pathological player
2020, International Journal of Biological MacromoleculesCitation Excerpt :APP/PS1 mice treated with Rolipram showed a comparable long-term potentiation (LTP) induction which is prevalently found to be scarce in the APP/PS1 mouse model of AD. Also, Rolipram was noted to enhance the proteasome system by increasing the phosphorylation of PKA (mediator of proteasome function) and other proteasome systems [254–256]. By investigating the connection between neurodegenerative diseases and autophagy has put forward an interesting question of whether modulating autophagy could reduce protein aggregation and ameliorate cell degeneration.
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability
2019, Bioorganic and Medicinal ChemistryCitation Excerpt :The highest concentrations of PDE4B and PDE4D are found in specific brain regions such as the nucleus accumbens shell and the frontal cortex, which suggests their role in depression, schizophrenia, and cognitive process.13 To date, a plethora of different structurally related molecules have been reported including the first prototypical PDE4-selective inhibitor, rolipram, which has shown behavioral and antidepressant effect in rats and humans.14–16 Another molecule, RO-20-1724, has been shown to exhibit antipsychotic-like properties as well as neuroprotective effect.17,18
Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays
2017, Cellular SignallingCitation Excerpt :The PDE4 family, composed of four genes (PDE4A-4D), has long been seen as a promising drug target involved in inflammation and psychiatric disease. For example, rolipram, the drug that defines the PDE4 family, displays both anti-inflammatory and anti-depressant activity [7,8]. However, efforts to develop rolipram, and most other PDE4 inhibitors, as a therapeutic have been hampered by common side-effects such as emesis and nausea [9], although some success has been seen with Roflumilast to treat chronic obstructive pulmonary disease and Apremilast to treat psoriasis and psoriatic arthritis [10].
Determination of a novel phosphodiesterase-4 inhibitor chlorbipram in mouse plasma and brain by UFLC-MS/MS: Application in pharmacokinetic studies after intravenous administration
2015, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences